Impact of Plasma Tissue Inhibitor of Matrix Metalloproteinase-1 on Long-Term Survival in Patients with Colorectal Cancer

Publisher： Karger

E-ISSN： 1423-0232|72|3-4|205-208

ISSN： 0030-2414

Source： Oncology, Vol.72, Iss.3-4, 2007-12, pp. : 205-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Long-Term Influence of Tissue Inhibitor of Matrix Metalloproteinase-1 in Patients with Mild to Moderate Coronary Artery Lesions in a Chinese Population: A 7-Year Follow-Up Study

By  

Cardiology, Vol. 132, Iss. 3, 2015-0 ,pp. : 151-158

Karger

Access to resources Recommend Favorite

Tissue inhibitor of metalloproteinase-1 levels in plasma from tumour arteries and veins of patients with rectal cancer

By Frederiksen C.   Lykke J.   Christensen Ib J.   Brünner N.   Nielsen H. J.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 67, Iss. 5, 2007-01 ,pp. : 545-552

Informa Healthcare

Access to resources Recommend Favorite

Enhanced Exhalation of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Patients with COPD Exacerbation: A Prospective Study

By  

Respiration, Vol. 84, Iss. 3, 2012-07 ,pp. : 231-241

Karger

Access to resources Recommend Favorite

Tissue Inhibitor of Metalloproteinase-1: Actions beyond Matrix Metalloproteinase Inhibition

By  

Cardiology, Vol. 132, Iss. 3, 2015-0 ,pp. : 147-150

Karger

Access to resources Recommend Favorite

Long-Term Survival in Patients with Inoperable and Metastasized Cancer

By  

Oncology Research and Treatment, Vol. 31, Iss. 8-9, 2008-07 ,pp. : 427-428

Karger

Access to resources Recommend Favorite